Metamark Genetics is a privately-held biotechnology company founded to develop novel, function-based prognostic and diagnostic tests aimed at improving urological cancer care. Metamark is a provider of specialty urological pathology testing services ...Show all
Company (Alive / Active)
Phone: 617-583-1400
283 Bear Hill Road
Waltham, 02451
Massachusetts, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Name | Firm |
---|---|
Login to see details | Physiome Sciences |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Tumor markers fus, smad4, derl1, ybx1, ps6, pdss2, cul2, and hspa9 for analyzing prostate tumor samples | Jun 05, 2019 | Application | |
Compositions and methods for cancer prognosis | Mar 14, 2014 | Application |